Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Bio-Raider Gene Technology is a biotechnology company focused on precision medicine and molecular diagnostics, headquartered in Wuhan, China. The company specializes in high-throughput sequencing (NGS) and bioinformatics to develop solutions for early cancer screening, companion diagnostics, and genetic disease testing. Their product portfolio includes non-invasive liquid biopsy kits and methylation-based detection assays for various malignancies, such as colorectal and lung cancer. Bio-Raider operates a clinical laboratory and provides comprehensive genomic services to hospitals and research institutions. The firm is dedicated to advancing personalized healthcare through innovative genomic technologies and data-driven insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Bio-Raider Gene Technology.